Literature DB >> 21963651

Absence of SOD1 leads to oxidative stress in peripheral nerve and causes a progressive distal motor axonopathy.

Lindsey R Fischer1, Yingjie Li, Seneshaw A Asress, Dean P Jones, Jonathan D Glass.   

Abstract

Oxidative stress is commonly implicated in the pathogenesis of motor neuron disease. However, the cause and effect relationship between oxidative stress and motor neuron degeneration is poorly defined. We recently identified denervation at the neuromuscular junction in mice lacking the antioxidant enzyme, Cu,Zn-superoxide dismutase (SOD1) (Fischer et al., 2011). These mice show a phenotype of progressive muscle atrophy and weakness in the setting of chronic oxidative stress. Here, we investigated further the extent of motor neuron pathology in this model, and the relationship between motor pathology and oxidative stress. We report preferential denervation of fast-twitch muscles beginning between 1 and 4 months of age, with relative sparing of slow-twitch muscle. Motor axon terminals in affected muscles show widespread sprouting and formation of large axonal swellings. We confirmed, as was previously reported, that spinal motor neurons and motor and sensory nerve roots in these mice are preserved, even out to 18 months of age. We also found preservation of distal sensory fibers in the epidermis, illustrating the specificity of pathology in this model for distal motor axons. Using HPLC measurement of the glutathione redox potential, we quantified oxidative stress in peripheral nerve and muscle at the onset of denervation. SOD1 knockout tibial nerve, but not gastrocnemius muscle, showed significant oxidation of the glutathione pool, suggesting that axonal degeneration is a consequence of impaired redox homeostasis in peripheral nerve. We conclude that the SOD1 knockout mouse is a model of oxidative stress-mediated motor axonopathy. Pathology in this model primarily affects motor axon terminals at the neuromuscular junction, demonstrating the vulnerability of this synapse to oxidative injury.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21963651      PMCID: PMC4068963          DOI: 10.1016/j.expneurol.2011.09.020

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  37 in total

1.  SOD1 targeted to the mitochondrial intermembrane space prevents motor neuropathy in the Sod1 knockout mouse.

Authors:  Lindsey R Fischer; Anissa Igoudjil; Jordi Magrané; Yingjie Li; Jason M Hansen; Giovanni Manfredi; Jonathan D Glass
Journal:  Brain       Date:  2010-11-14       Impact factor: 13.501

Review 2.  ALS: a disease of motor neurons and their nonneuronal neighbors.

Authors:  Séverine Boillée; Christine Vande Velde; Don W Cleveland
Journal:  Neuron       Date:  2006-10-05       Impact factor: 17.173

Review 3.  Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target.

Authors:  Siân C Barber; Richard J Mead; Pamela J Shaw
Journal:  Biochim Biophys Acta       Date:  2006-04-04

4.  Time course of preferential motor unit loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.

Authors:  J Hegedus; C T Putman; T Gordon
Journal:  Neurobiol Dis       Date:  2007-07-10       Impact factor: 5.996

5.  Redox modifier genes in amyotrophic lateral sclerosis in mice.

Authors:  Jennifer J Marden; Maged M Harraz; Aislinn J Williams; Kathryn Nelson; Meihui Luo; Henry Paulson; John F Engelhardt
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

6.  SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model.

Authors:  Maged M Harraz; Jennifer J Marden; Weihong Zhou; Yulong Zhang; Aislinn Williams; Victor S Sharov; Kathryn Nelson; Meihui Luo; Henry Paulson; Christian Schöneich; John F Engelhardt
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

7.  Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy.

Authors:  Lyndsay M Murray; Laura H Comley; Derek Thomson; Nick Parkinson; Kevin Talbot; Thomas H Gillingwater
Journal:  Hum Mol Genet       Date:  2007-12-08       Impact factor: 6.150

8.  Denervation-induced skeletal muscle atrophy is associated with increased mitochondrial ROS production.

Authors:  Florian L Muller; Wook Song; Youngmok C Jang; Yuhong Liu; Marian Sabia; Arlan Richardson; Holly Van Remmen
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2007-06-20       Impact factor: 3.619

Review 9.  Current hypotheses for the underlying biology of amyotrophic lateral sclerosis.

Authors:  Jeffrey D Rothstein
Journal:  Ann Neurol       Date:  2009-01       Impact factor: 10.422

10.  Induction of cell stress in neurons from transgenic mice expressing yellow fluorescent protein: implications for neurodegeneration research.

Authors:  Laura H Comley; Thomas M Wishart; Becki Baxter; Lyndsay M Murray; Ailish Nimmo; Derek Thomson; Simon H Parson; Thomas H Gillingwater
Journal:  PLoS One       Date:  2011-03-08       Impact factor: 3.240

View more
  35 in total

1.  Calcium dysregulation mediates mitochondrial and neurite outgrowth abnormalities in SOD2 deficient embryonic cerebral cortical neurons.

Authors:  Qijin Zhao; Daoyuan Lu; Jing Wang; Beibei Liu; Heping Cheng; Mark P Mattson; Aiwu Cheng
Journal:  Cell Death Differ       Date:  2018-11-02       Impact factor: 15.828

2.  Dissection of the transversus abdominis muscle for whole-mount neuromuscular junction analysis.

Authors:  Lyndsay Murray; Thomas H Gillingwater; Rashmi Kothary
Journal:  J Vis Exp       Date:  2014-01-11       Impact factor: 1.355

3.  Copper-zinc superoxide dismutase-deficient mice show increased susceptibility to experimental autoimmune encephalomyelitis induced with myelin oligodendrocyte glycoprotein 35-55.

Authors:  Chandirasegaran Massilamany; Arunakumar Gangaplara; Heejeong Kim; Charlotte Stanford; Govardhan Rathnaiah; David Steffen; Jaekwon Lee; Jay Reddy
Journal:  J Neuroimmunol       Date:  2013-01-05       Impact factor: 3.478

Review 4.  Superoxide dismutases and superoxide reductases.

Authors:  Yuewei Sheng; Isabel A Abreu; Diane E Cabelli; Michael J Maroney; Anne-Frances Miller; Miguel Teixeira; Joan Selverstone Valentine
Journal:  Chem Rev       Date:  2014-04-01       Impact factor: 60.622

Review 5.  Mechanisms of Muscle Denervation in Aging: Insights from a Mouse Model of Amyotrophic Lateral Sclerosis.

Authors:  Kevin H J Park
Journal:  Aging Dis       Date:  2015-10-01       Impact factor: 6.745

6.  SOD1 deficiency: a novel syndrome distinct from amyotrophic lateral sclerosis.

Authors:  Julien H Park; Christiane Elpers; Janine Reunert; Michael L McCormick; Julia Mohr; Saskia Biskup; Oliver Schwartz; Stephan Rust; Marianne Grüneberg; Anja Seelhöfer; Ulrike Schara; Eugen Boltshauser; Douglas R Spitz; Thorsten Marquardt
Journal:  Brain       Date:  2019-08-01       Impact factor: 13.501

Review 7.  β-Secretase: its biology as a therapeutic target in diseases.

Authors:  Haibo Wang; Rena Li; Yong Shen
Journal:  Trends Pharmacol Sci       Date:  2013-02-27       Impact factor: 14.819

8.  Prion-like propagation of mutant SOD1 misfolding and motor neuron disease spread along neuroanatomical pathways.

Authors:  Jacob I Ayers; Susan E Fromholt; Veronica M O'Neal; Jeffrey H Diamond; David R Borchelt
Journal:  Acta Neuropathol       Date:  2015-12-09       Impact factor: 17.088

Review 9.  Oxidative stress in hypertension: role of the kidney.

Authors:  Magali Araujo; Christopher S Wilcox
Journal:  Antioxid Redox Signal       Date:  2013-04-30       Impact factor: 8.401

10.  Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models.

Authors:  Alex McCampbell; Tracy Cole; Amy J Wegener; Giulio S Tomassy; Amy Setnicka; Brandon J Farley; Kathleen M Schoch; Mariah L Hoye; Mark Shabsovich; Linhong Sun; Yi Luo; Mingdi Zhang; Nicole Comfort; Bin Wang; Jessica Amacker; Sai Thankamony; David W Salzman; Merit Cudkowicz; Danielle L Graham; C Frank Bennett; Holly B Kordasiewicz; Eric E Swayze; Timothy M Miller
Journal:  J Clin Invest       Date:  2018-07-16       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.